logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

TofacitinibTruncal maculopapular rash and off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2019年 / 1751卷 / 1期
关键词:
D O I:
10.1007/s40278-019-61488-x
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:355 / 355
相关论文
共 50 条
  • [31] FavipiravirNephrotoxicity following off-label use: case report
    Reactions Weekly, 2022, 1929 (1) : 283 - 283
  • [32] BevacizumabRetinal breaks and off-label use: case report
    Reactions Weekly, 2022, 1924 (1) : 120 - 120
  • [33] Mirtazapine/pregabalinDelirium and off-label use: case report
    Reactions Weekly, 2024, 2029 (1) : 384 - 384
  • [34] DexamfetamineHypertension following off-label use: case report
    Reactions Weekly, 2021, 1883 (1) : 150 - 150
  • [35] DexamethasoneHyperglycaemia following off-label use: case report
    Reactions Weekly, 2022, 1896 (1) : 173 - 173
  • [36] DexamethasoneAspergillosis secondary to off-label use: case report
    Reactions Weekly, 2022, 1935 (1) : 177 - 177
  • [37] TocilizumabAnaphylaxis following off-label use: case report
    Reactions Weekly, 2021, 1865 (1) : 397 - 397
  • [38] MirtazapineTachyphylaxis following off-label use: case report
    Reactions Weekly, 2018, 1703 (1) : 182 - 182
  • [39] RituximabPancytopenia following off-label use: case report
    Reactions Weekly, 2020, 1807 (1) : 176 - 176
  • [40] AntineoplasticsLack of efficacy and off-label use: case report
    Reactions Weekly, 2021, 1866 (1) : 47 - 47
← 12345 →